▁This 4.47265625
▁type 7.43359375
▁of 0.09271240234375
▁study 6.09765625
▁is 1.1513671875
▁the 3.345703125
▁most 1.259765625
▁reve 7.984375
aling 0.0013875961303710938
▁and 1.98828125
▁inclus 7.60546875
ive 0.0008702278137207031
, 3.09375
▁as 1.8720703125
▁it 0.447998046875
▁contains 5.38671875
▁direct 6.5
▁responses 4.57421875
▁from 0.55615234375
▁a 3.14453125
▁large 1.97265625
▁number 1.232421875
▁of 0.00920867919921875
▁participants 2.845703125
. 0.63818359375
▁All 5.39453125
▁tools 9.359375
▁in 2.82421875
▁the 1.5068359375
▁form 5.5859375
▁of 0.119384765625
▁question 1.0302734375
na 0.050750732421875
ires 0.0001595020294189453
▁and 2.150390625
▁scales 4.01953125
▁have 2.95703125
▁already 5.3125
▁been 0.10992431640625
▁used 4.34765625
▁and 1.728515625
▁proved 5.10546875
▁their 1.6953125
▁effic 3.73828125
acy 0.03375244140625
▁for 3.689453125
▁collect 3.890625
ing 0.00698089599609375
▁analyt 9.515625
ical 0.140380859375
▁data 0.331787109375
. 0.4873046875
▁It 3.626953125
▁helps 4.53125
▁to 0.5859375
▁system 5.76953125
at 0.2191162109375
ize 0.11151123046875
▁and 1.6298828125
▁class 3.796875
ify 0.0016374588012695312
▁distinct 9.578125
▁kinds 6.47265625
▁of 0.0201416015625
▁information 1.39453125
▁for 4.64453125
▁subsequent 4.9140625
▁un 8.0390625
comp 4.59765625
licated 0.0175933837890625
▁services 11.4453125
. 0.95947265625
▁Thus 5.84765625
, 0.07733154296875
▁research 4.5
ers 0.76318359375
▁can 1.296875
▁compare 3.76953125
▁the 1.36328125
▁effects 5.75
▁of 0.1529541015625
▁medic 5.97265625
ations 0.8896484375
▁on 1.62890625
▁patients 2.416015625
▁of 2.876953125
▁diverse 4.04296875
▁age 1.2958984375
▁groups 1.2021484375
, 0.74267578125
▁background 4.671875
s 0.11151123046875
, 0.2193603515625
▁physical 5.21875
▁conditions 1.552734375
, 0.2646484375
▁emot 6.77734375
ional 0.05010986328125
▁states 0.97705078125
, 0.2318115234375
▁and 0.775390625
▁so 1.6826171875
▁on 0.257568359375
. 0.08673095703125
<0x0A> 0.80322265625
The 2.01171875
▁analysis 5.16015625
▁of 0.3857421875
▁any 5.92578125
▁human 7.1796875
▁reaction 4.5
▁has 4.59765625
▁a 1.9755859375
▁high 3.677734375
▁potential 3.16796875
▁of 1.8984375
▁subject 5.390625
iveness 3.662109375
▁and 1.66796875
▁bias 2.076171875
, 1.6796875
▁especially 3.265625
▁regarding 5.4296875
▁people 5.078125
▁in 4.390625
▁severe 5.28515625
▁pain 2.26171875
▁and 2.365234375
▁un 4.984375
stable 1.08984375
▁emot 1.111328125
ional 0.0748291015625
▁condition 3.234375
. 0.1060791015625
▁Perhaps 8.5703125
▁some 5.671875
▁patients 2.421875
▁tend 4.60546875
▁to 0.01158905029296875
▁ex 1.671875
agger 0.0098876953125
ate 0.0016660690307617188
▁their 1.197265625
▁de 7.46484375
press 1.6376953125
ive 0.15380859375
▁state 1.5498046875
▁or 1.6884765625
▁vice 5.02734375
▁vers 0.032135009765625
a 4.76837158203125e-05
, 0.90380859375
▁de 7.55859375
- 3.087890625
emph 0.2174072265625
as 0.0032596588134765625
ize 0.08050537109375
▁serious 5.62890625
▁difficulties 5.35546875
. 0.86083984375
▁Because 6.453125
▁the 3.462890625
▁survey 3.681640625
▁responses 5.5546875
▁were 4.56640625
▁thoroughly 7.95703125
▁anonymous 3.88671875
, 0.2313232421875
▁the 1.5078125
▁research 1.29296875
ers 0.234130859375
▁were 1.94140625
▁unable 4.02734375
▁to 0.00383758544921875
▁carefully 8.3125
▁analyze 2.513671875
▁each 2.451171875
▁patient 2.517578125
’ 0.55078125
s 0.0012302398681640625
▁reaction 3.79296875
▁and 1.697265625
▁compare 3.7734375
▁it 0.78759765625
▁to 0.67041015625
▁the 1.1181640625
▁actual 4.7734375
▁states 8.4453125
▁of 0.7978515625
▁condition 7.08984375
. 0.5458984375
▁More 6.8828125
▁accurate 3.396484375
▁answers 4.56640625
▁could 1.6962890625
▁be 0.591796875
▁obtained 1.0888671875
▁by 1.78515625
▁professional 6.05859375
▁psych 1.7529296875
olog 0.269287109375
ists 0.0020809173583984375
▁via 6.78125
▁personal 2.322265625
▁communication 4.30859375
▁and 2.537109375
▁behavior 6.2734375
al 0.35986328125
▁analysis 2.16015625
. 0.32470703125
▁However 2.92578125
, 0.00397491455078125
▁this 1.611328125
▁method 1.8779296875
▁of 2.453125
▁research 1.708984375
▁is 1.228515625
▁way 5.390625
▁more 1.0478515625
▁resource 4.62109375
- 0.408447265625
int 1.43359375
ensive 0.01727294921875
▁and 0.533203125
▁energy 10.296875
- 0.11785888671875
consum 0.438232421875
ing 0.003238677978515625
. 0.79833984375
<0x0A> 0.44873046875
Chr 9.4453125
onic 0.11102294921875
▁pain 0.40625
▁is 1.1279296875
▁still 4.85546875
▁considered 2.8984375
▁to 1.4482421875
▁be 0.0213165283203125
▁an 2.3828125
▁extreme 6.171875
▁issue 4.296875
▁among 3.728515625
▁at 10.453125
▁least 0.2491455078125
▁ 0.69189453125
8 3.474609375
% 2.005859375
▁of 0.05059814453125
▁the 0.55615234375
▁residents 7.5625
▁of 0.3779296875
▁progress 10.7890625
ive 0.09033203125
▁countries 0.5068359375
. 0.437744140625
▁The 2.08984375
▁introduction 6.75
▁of 0.016510009765625
▁the 2.771484375
▁study 4.8203125
▁describes 8.2109375
▁the 0.72509765625
▁apparent 8.6484375
▁link 5.359375
▁between 0.11712646484375
▁pain 2.53515625
▁and 0.395263671875
▁dem 7.24609375
oral 1.994140625
ization 0.0443115234375
. 1.2431640625
▁Chron 5.10546875
ic 0.01448822021484375
▁pain 0.24560546875
▁is 1.419921875
▁always 4.96875
▁accompanied 1.6142578125
▁by 0.0791015625
▁negative 3.578125
▁emot 0.59765625
ional 0.8359375
▁experiences 3.869140625
▁and 1.8154296875
▁blocks 10.296875
▁a 3.09765625
▁person 0.80078125
’ 0.37255859375
s 0.0009379386901855469
▁ability 1.4755859375
▁to 0.042205810546875
▁receive 6.15625
▁joy 3.171875
▁and 1.130859375
▁satisfaction 2.427734375
▁from 0.6298828125
▁life 0.9248046875
. 0.220703125
▁The 1.869140625
▁research 2.216796875
▁investig 6.23828125
ates 0.427490234375
▁the 0.479736328125
▁development 6.19921875
▁of 0.1241455078125
▁de 3.080078125
pression 0.57861328125
▁and 1.41796875
▁anx 1.4423828125
iety 0.0018053054809570312
▁among 1.8916015625
▁patients 1.0390625
▁receiving 5.84765625
▁ph 4.69140625
arma 2.0859375
ce 0.00791168212890625
ut 1.0728836059570312e-05
ical 0.00789642333984375
▁op 5.5625
io 0.1011962890625
ids 0.382568359375
▁and 2.48046875
▁medical 4.80078125
▁mar 1.2607421875
iju 0.0012416839599609375
ana 3.5762786865234375e-05
▁( 3.638671875
MM 1.7607421875
) 3.44140625
▁as 2.044921875
▁severe 9.4375
▁pain 0.61083984375
kill 1.966796875
ers 0.0002636909484863281
. 0.10858154296875
▁It 3.0390625
▁comp 4.140625
ares 0.00905609130859375
▁the 0.51171875
▁effic 4.09765625
acy 0.002048492431640625
▁of 0.2724609375
▁pres 6.02734375
cri 2.30859375
ptions 0.6025390625
▁and 1.4384765625
▁exam 4.4609375
ines 0.005138397216796875
▁the 0.53173828125
▁possibility 4.15234375
▁of 0.088623046875
▁post 8.2109375
- 0.440185546875
tre 1.650390625
at 0.0015840530395507812
ment 0.004314422607421875
▁de 1.201171875
pression 0.1580810546875
. 1.33203125
<0x0A> 0.358154296875
The 0.73583984375
▁study 1.716796875
▁was 1.810546875
▁conducted 0.7021484375
▁in 1.2099609375
▁the 1.451171875
▁form 2.591796875
▁of 0.0015478134155273438
▁collection 10.359375
▁and 0.75146484375
▁analysis 0.442626953125
▁of 0.0203857421875
▁statistical 3.9375
▁data 0.166015625
. 1.05078125
▁Part 4.51171875
icip 0.08038330078125
ants 0.043853759765625
▁were 0.638671875
▁rec 3.55078125
ru 0.0005145072937011719
ited 4.851818084716797e-05
▁for 4.28515625
▁six 6.5703125
▁months 0.5
▁at 3.46875
▁two 2.638671875
▁major 3.3515625
▁pain 2.921875
▁relief 3.67578125
▁cent 0.85205078125
ers 0.01641845703125
▁in 0.7646484375
▁Israel 5.03125
. 0.45166015625
▁The 1.2275390625
▁research 2.419921875
ers 1.06640625
▁used 2.28515625
▁The 8.078125
▁De 3.408203125
pression 0.04315185546875
▁Module 5.73828125
▁of 0.77587890625
▁the 0.259765625
▁Pat 2.9140625
ient 0.0092010498046875
▁Health 0.029388427734375
▁Question 0.018890380859375
naire 0.0196990966796875
▁and 2.888671875
▁the 0.8896484375
▁General 1.392578125
ized 0.6044921875
▁An 0.005584716796875
x 0.0001227855682373047
iety 0.00035381317138671875
▁Dis 0.2098388671875
order 0.02667236328125
▁Sc 1.556640625
ale 0.002071380615234375
▁to 1.083984375
▁interview 7.765625
▁participants 3.45703125
, 3.91796875
▁evaluate 4.66796875
▁their 0.51904296875
▁answers 3.828125
, 0.237060546875
▁and 0.038421630859375
▁conduct 5.23046875
▁the 2.03125
▁study 2.51171875
. 0.1318359375
▁To 5.046875
▁specifically 9.5859375
▁evaluate 3.54296875
▁and 4.72265625
▁compare 0.75
▁the 0.394775390625
▁prob 9.734375
abilities 0.037384033203125
▁of 0.07086181640625
▁de 0.857421875
pression 0.11199951171875
▁or 4.26953125
▁anx 0.08966064453125
iety 0.0009655952453613281
▁among 1.7392578125
▁the 2.080078125
▁diverse 7.98046875
▁groups 0.85546875
, 0.9951171875
▁the 0.53955078125
▁study 2.9765625
▁used 1.4638671875
▁multiple 5.48046875
▁log 0.87060546875
istic 0.02392578125
▁regression 0.27001953125
▁analysis 1.349609375
▁and 2.51171875
▁chose 8.859375
▁medical 6.20703125
▁mar 0.1339111328125
iju 0.0011386871337890625
ana 7.987022399902344e-05
▁as 0.5458984375
▁the 0.85546875
▁control 2.80859375
▁group 0.68505859375
. 0.24267578125
<0x0A> 0.301025390625
One 5.703125
▁of 0.297607421875
▁the 0.006229400634765625
▁major 2.361328125
▁limitations 3.85546875
▁is 3.216796875
▁the 0.448974609375
▁ins 4.3671875
u 0.08648681640625
fficient 0.1800537109375
ly 3.642578125
▁high 3.01171875
▁response 3.1171875
▁rate 0.11541748046875
, 2.048828125
▁ 4.08203125
5 1.853515625
7 2.3671875
% 1.2177734375
▁instead 4.8671875
▁of 0.0026378631591796875
▁ 0.77978515625
7 1.1005859375
0 0.57958984375
% 1.3623046875
▁( 3.05078125
Fe 9.6015625
ing 0.916015625
old 0.7587890625
▁et 1.52734375
▁al 0.0292510986328125
., 0.29443359375
▁ 0.019195556640625
2 0.0513916015625
0 0.0005502700805664062
1 0.27734375
7 1.828125
). 0.1263427734375
▁It 2.55859375
▁can 2.98828125
▁be 0.445068359375
▁fairly 7.75390625
▁explained 1.4453125
▁by 0.2177734375
▁the 0.2421875
▁weak 7.59765625
▁focus 6.9296875
▁of 0.7216796875
▁respond 6.0703125
ents 0.1832275390625
▁who 3.91796875
▁have 3.484375
▁overcome 8.40625
▁severe 2.0234375
▁pain 0.54345703125
▁sens 8.6875
ations 0.285888671875
▁and 0.79541015625
▁de 4.85546875
press 1.177734375
ive 0.049468994140625
▁episodes 1.955078125
. 0.66943359375
▁It 3.033203125
▁is 0.70751953125
▁not 2.876953125
▁clear 3.607421875
▁how 1.9296875
▁to 3.73046875
▁use 4.76953125
▁these 2.982421875
▁statistics 3.5234375
, 3.228515625
▁as 0.498046875
▁they 2.154296875
▁still 5.0859375
▁may 4.29296875
▁be 1.27734375
▁relevant 5.515625
▁for 1.4326171875
▁the 1.724609375
▁overall 5.11328125
▁analysis 2.763671875
. 0.9931640625
<0x0A> 1.486328125
Part 5.66015625
icip 0.143310546875
ants 0.12353515625
▁were 1.185546875
▁rec 2.86328125
ru 0.0005197525024414062
ited 1.7404556274414062e-05
▁for 2.771484375
▁six 0.8974609375
▁months 0.013885498046875
▁at 0.8564453125
▁two 0.1466064453125
▁major 0.27490234375
▁pain 0.0787353515625
▁relief 0.0374755859375
▁cent 0.0200958251953125
ers 0.0004887580871582031
▁in 0.0963134765625
▁Israel 0.018157958984375
. 0.278076171875
▁All 4.2265625
▁patients 1.6259765625
▁experienced 5.6953125
▁chron 1.4423828125
ic 0.00022971630096435547
▁pain 0.26171875
▁for 2.029296875
▁at 0.66162109375
▁least 0.001972198486328125
▁ 1.6171875
3 1.2294921875
▁months 0.14306640625
. 1.5029296875
▁The 1.4072265625
▁study 2.0078125
▁included 1.6953125
▁ 0.6005859375
8 3.130859375
9 2.4609375
0 3.001953125
▁participants 1.55078125
, 1.279296875
▁of 2.88671875
▁which 0.49462890625
▁ 0.0965576171875
4 1.541015625
7 2.408203125
4 2.64453125
▁( 2.748046875
5 0.09112548828125
9 5.69140625
%) 0.48828125
▁were 0.8564453125
▁treated 2.8515625
▁sole 6.7265625
ly 0.0001513957977294922
▁with 0.09710693359375
▁op 0.81103515625
io 0.04010009765625
ids 0.1654052734375
, 0.62451171875
▁ 0.55615234375
3 1.2109375
2 2.298828125
9 2.474609375
▁( 0.05841064453125
4 2.576171875
1 1.5830078125
%) 0.0521240234375
▁were 1.458984375
▁treated 0.66015625
▁with 0.22607421875
▁MM 0.74462890625
, 0.44580078125
▁and 0.114013671875
▁ 0.1937255859375
7 2.029296875
7 1.8466796875
▁( 0.127197265625
8 1.59375
. 1.05859375
6 2.126953125
%) 0.04949951171875
▁acquired 10.265625
▁both 0.53466796875
▁( 3.919921875
Fe 0.18359375
ing 0.0013408660888671875
old 0.00019311904907226562
▁et 0.01126861572265625
▁al 0.00063323974609375
., 0.007335662841796875
▁ 0.0009284019470214844
2 0.00015366077423095703
0 3.230571746826172e-05
1 0.0005197525024414062
7 0.00301361083984375
). 0.005664825439453125
▁The 1.2275390625
▁remaining 7.28515625
▁ten 6.859375
▁participants 1.2197265625
▁who 4.5546875
▁did 2.16796875
▁not 0.005565643310546875
▁receive 2.400390625
▁ph 4.33984375
arma 0.1241455078125
ce 0.00234222412109375
ut 4.0531158447265625e-06
ical 0.0046234130859375
▁op 2.185546875
io 0.01861572265625
ids 0.030059814453125
▁and 2.5234375
▁medical 2.294921875
▁mar 0.0645751953125
iju 0.0003380775451660156
ana 2.872943878173828e-05
▁were 0.40966796875
▁with 6.56640625
dra 0.057952880859375
wn 4.76837158203125e-05
▁from 0.2451171875
▁the 0.186279296875
▁analysis 2.20703125
▁in 5.3046875
▁the 1.0869140625
▁research 4.59375
. 0.8779296875
▁Therefore 5.37109375
, 0.007030487060546875
▁it 3.361328125
▁is 0.76904296875
▁not 2.107421875
▁possible 1.4599609375
▁to 0.00403594970703125
▁compreh 5.578125
ens 0.1148681640625
ively 0.026947021484375
▁compare 0.9619140625
▁patients 4.91015625
▁taking 4.140625
▁medic 3.859375
ations 0.40625
▁with 1.466796875
▁those 1.021484375
▁who 0.65673828125
▁do 1.7626953125
▁not 0.00363922119140625
. 0.60791015625
<0x0A> 0.458740234375
Am 5.19140625
ong 0.00519561767578125
▁all 2.208984375
▁participants 1.150390625
▁in 3.92578125
▁the 0.1414794921875
▁study 0.411376953125
, 0.055816650390625
▁ 0.62841796875
4 1.8701171875
2 2.255859375
. 1.5478515625
2 2.2578125
% 0.0450439453125
▁suffered 3.455078125
▁from 0.04840087890625
▁de 1.1513671875
pression 0.17626953125
, 0.91357421875
▁and 1.3447265625
▁ 0.0977783203125
3 1.404296875
7 2.3203125
% 2.396484375
▁experienced 2.20703125
▁excess 6.96484375
ive 0.0269317626953125
▁anx 0.175048828125
iety 0.0021610260009765625
. 0.55029296875
▁The 1.4111328125
▁pl 10.9375
ur 0.6826171875
ality 0.0006403923034667969
▁of 0.14892578125
▁de 2.76171875
press 1.3017578125
ive 0.030670166015625
▁dis 3.51171875
orders 0.127197265625
▁among 2.984375
▁patients 1.1201171875
▁in 3.95703125
▁the 0.95654296875
▁op 1.5185546875
i 5.76171875
ates 0.0369873046875
, 7.23828125
▁medical 2.84765625
▁mar 0.043060302734375
iju 0.0018949508666992188
ana 2.1576881408691406e-05
, 0.1845703125
▁and 0.07330322265625
▁mixed 1.9697265625
▁OP 10.6640625
MM 4.1015625
▁groups 0.61767578125
▁number 8.7578125
ed 0.03326416015625
▁ 0.149658203125
5 2.26953125
7 2.705078125
. 0.65283203125
1 2.53125
%, 0.2412109375
▁ 0.005252838134765625
2 2.404296875
2 2.69140625
. 0.1219482421875
3 2.271484375
%, 0.041107177734375
▁and 0.04852294921875
▁ 0.0017156600952148438
5 2.23046875
1 2.12890625
. 0.19580078125
4 1.75
%, 0.1806640625
▁respectively 0.02288818359375
. 0.63330078125
▁The 1.1611328125
▁pl 3.306640625
ur 0.01049041748046875
ality 1.3589859008789062e-05
▁of 0.0278472900390625
▁anx 0.389404296875
iety 0.0218658447265625
▁contained 10.9296875
▁ 0.271728515625
4 1.1708984375
8 2.3984375
. 0.189453125
4 2.19921875
% 1.759765625
▁among 2.2890625
▁OP 4.00390625
▁patients 5.28515625
, 0.2069091796875
▁ 0.06878662109375
2 1.0126953125
1 2.517578125
. 0.126220703125
5 2.07421875
% 0.02532958984375
▁among 0.3447265625
▁MM 0.10223388671875
▁patients 0.390625
, 0.0191192626953125
▁and 0.0170745849609375
▁ 0.0238494873046875
3 1.4140625
8 1.9462890625
. 0.1376953125
7 2.439453125
% 0.01274871826171875
▁among 0.203857421875
▁OP 1.94921875
MM 0.128662109375
▁participants 3.07421875
. 0.54296875
▁Pat 5.32421875
ients 0.017547607421875
▁who 1.28515625
▁took 2.283203125
▁strong 9.6640625
▁op 0.9287109375
i 1.0556640625
ates 0.0033054351806640625
▁were 1.6982421875
▁t 9.734375
ended 0.87548828125
▁to 0.0084228515625
▁place 10.1875
▁their 2.611328125
▁pain 3.19140625
▁on 1.931640625
▁a 0.81201171875
▁scale 2.365234375
▁of 0.302001953125
▁ 0.1787109375
9 2.3984375
▁to 2.43359375
▁ 0.01171112060546875
1 0.00954437255859375
0 0.04840087890625
▁( 2.126953125
Fe 0.76806640625
ing 0.0019102096557617188
old 0.00030612945556640625
▁et 0.00432586669921875
▁al 0.0006694793701171875
., 0.00586700439453125
▁ 0.0005307197570800781
2 0.00016546249389648438
0 2.1338462829589844e-05
1 0.0005521774291992188
7 0.002017974853515625
). 0.01496124267578125
▁They 3.771484375
▁were 1.734375
▁also 1.0810546875
▁an 9.2109375
gu 3.88671875
ished 0.0657958984375
▁em 6.36328125
otion 0.00116729736328125
ally 0.0005311965942382812
▁and 0.8876953125
▁react 7.0703125
ed 0.0202484130859375
▁rad 8.6796875
ically 0.0012073516845703125
▁neg 4.9921875
atively 0.0014390945434570312
▁to 0.1815185546875
▁almost 5.3515625
▁all 1.4853515625
▁survey 4.23046875
▁questions 0.26318359375
. 0.317626953125
▁Pat 3.294921875
ients 0.004795074462890625
▁who 0.7646484375
▁took 1.4755859375
▁only 4.109375
▁MM 0.46826171875
▁or 2.87109375
▁mixed 2.296875
▁medic 1.271484375
ations 0.1617431640625
▁course 13.96875
▁had 2.5546875
▁a 1.4833984375
▁significantly 2.9921875
▁more 3.533203125
▁stable 2.861328125
▁emot 1.2412109375
ional 0.0013256072998046875
▁state 0.415771484375
▁and 1.009765625
▁cop 7.0546875
ed 0.0325927734375
▁with 0.3486328125
▁pain 1.0166015625
▁more 1.908203125
▁manage 7.546875
able 1.2021484375
. 0.3798828125
<0x0A> 0.461181640625
There 4.2109375
▁is 1.306640625
▁currently 7.0703125
▁a 1.412109375
▁severe 4.28515625
▁lack 1.673828125
▁of 0.01068878173828125
▁information 2.787109375
▁about 1.0283203125
▁the 0.4619140625
▁effects 2.63671875
▁of 0.05810546875
▁op 2.849609375
i 1.3671875
ates 0.0026092529296875
. 4.47265625
▁They 3.865234375
▁manage 9.0234375
▁pain 2.7578125
▁successfully 5.34765625
, 0.90625
▁but 0.221435546875
▁the 2.328125
▁past 9.5859375
▁few 3.021484375
▁dec 1.060546875
ades 0.00021851062774658203
▁indicated 6.82421875
▁the 1.732421875
▁growing 3.47265625
▁concern 3.64453125
▁regarding 2.615234375
▁op 2.93359375
iate 1.076171875
▁ab 1.583984375
use 0.01519012451171875
▁in 4.078125
▁forms 8.6640625
▁of 0.10369873046875
▁over 2.826171875
d 0.08154296875
ose 0.3544921875
▁and 0.7041015625
▁add 0.5947265625
iction 0.01538848876953125
. 0.1539306640625
▁A 4.515625
▁more 4.05078125
▁manage 6.94921875
able 0.00047707557678222656
▁and 1.794921875
▁sa 2.6953125
fer 7.641315460205078e-05
▁alternative 1.4765625
▁might 5.1875
▁be 0.12127685546875
▁medical 0.89697265625
▁mar 0.0301055908203125
iju 0.0003178119659423828
ana 4.839897155761719e-05
. 0.92724609375
▁However 2.533203125
, 0.0006237030029296875
▁the 1.69140625
▁legal 4.05859375
▁status 1.138671875
▁and 2.765625
▁novel 10.2734375
ty 0.08331298828125
▁of 0.1502685546875
▁this 1.861328125
▁drug 1.5654296875
▁do 4.2421875
▁not 0.01361846923828125
▁allow 0.62939453125
▁finding 7.34375
▁a 2.357421875
▁large 2.64453125
▁number 0.6982421875
▁of 0.0018911361694335938
▁studies 2.11328125
▁on 2.1171875
▁its 0.6181640625
▁effect 2.3046875
iveness 0.100341796875
. 0.7099609375
▁Specifically 9.0234375
, 0.160888671875
▁it 2.3203125
▁concerns 5.11328125
▁the 0.77099609375
▁emot 5.1015625
ional 0.0059814453125
▁condition 3.73828125
▁of 0.351318359375
▁patients 0.391357421875
▁experien 5.67578125
cing 2.086162567138672e-05
▁chron 0.7333984375
ic 0.00024044513702392578
▁pain 0.042388916015625
. 0.45849609375
▁This 2.326171875
▁research 1.5673828125
▁paper 5.7734375
▁a 4.09375
ims 0.01212310791015625
▁to 0.076416015625
▁analyze 3.46875
▁levels 9.2265625
▁of 0.03643798828125
▁de 0.42138671875
pression 0.05078125
▁and 0.1302490234375
▁anx 0.0218505859375
iety 0.0004131793975830078
▁among 0.494873046875
▁people 2.955078125
▁receiving 2.603515625
▁ther 6.796875
apy 0.12017822265625
▁by 4.8125
▁comparing 9.3125
▁the 1.5947265625
▁effects 1.8564453125
▁of 0.021575927734375
▁ph 1.7568359375
arma 0.016448974609375
ce 0.0009198188781738281
ut 4.291534423828125e-05
ical 0.0014848709106445312
▁op 0.060211181640625
io 0.56298828125
ids 0.020599365234375
▁and 0.58447265625
▁MM 2.220703125
. 0.302734375
<0x0A> 0.58544921875
The 0.73583984375
▁study 1.265625
▁conducted 3.90234375
▁a 2.02734375
▁correlation 6.43359375
▁type 9.3046875
▁of 0.223876953125
▁research 0.75927734375
▁with 3.291015625
▁variable 9.0703125
▁measures 5.515625
. 0.97265625
▁It 1.2626953125
▁evaluated 4.8984375
▁the 0.5712890625
▁inter 5.82421875
dep 2.505859375
end 0.0002677440643310547
ence 0.00927734375
▁of 0.5830078125
▁various 3.40625
▁factors 1.0654296875
▁that 3.203125
▁affected 3.83203125
▁the 0.51318359375
▁physical 6.0390625
▁and 0.32421875
▁emot 0.379638671875
ional 0.00017821788787841797
▁condition 1.802734375
▁of 0.03662109375
▁patients 0.6943359375
▁experien 3.115234375
cing 2.384185791015625e-06
▁chron 0.3310546875
ic 0.00018656253814697266
▁pain 0.017791748046875
. 0.136962890625
▁For 4.74609375
▁example 1.7880859375
, 0.0011730194091796875
▁the 0.9375
▁survey 4.98046875
▁showed 3.8828125
▁that 0.467529296875
▁the 1.6708984375
▁ratio 7.47265625
▁of 0.0880126953125
▁female 5.15234375
▁patients 0.99951171875
▁was 1.439453125
▁remark 7.71875
ably 0.00035190582275390625
▁higher 0.183349609375
▁in 2.36328125
▁the 0.50634765625
▁op 2.203125
i 0.77587890625
ates 0.0019550323486328125
▁group 0.39111328125
▁compared 2.685546875
▁to 0.04107666015625
▁the 0.74951171875
▁MM 0.58544921875
▁group 0.76025390625
. 0.6103515625
▁In 3.5625
▁turn 3.408203125
, 0.0009899139404296875
▁people 5.46484375
▁on 5.0078125
▁op 3.04296875
i 0.23876953125
ates 0.0018749237060546875
▁were 1.203125
▁more 0.880859375
▁likely 0.6953125
▁to 0.022491455078125
▁report 2.603515625
▁major 6.4765625
▁de 0.671875
press 0.63525390625
ive 0.0028095245361328125
▁dis 0.9189453125
orders 1.1591796875
. 1.591796875
<0x0A> 2.5390625
The 0.8349609375
▁question 6.29296875
na 1.5810546875
ires 8.618831634521484e-05
▁used 1.58984375
▁different 8.28125
▁variable 7.953125
▁measures 0.31201171875
▁to 1.8671875
▁collect 2.38671875
▁information 2.09765625
. 1.2431640625
▁For 1.8427734375
▁example 0.2379150390625
, 0.0009589195251464844
▁it 4.21484375
▁included 2.015625
▁compreh 8.359375
ensive 0.0567626953125
▁so 5.95703125
cio 0.0024662017822265625
- 0.214111328125
dem 0.0870361328125
ographic 0.06744384765625
▁data 0.8828125
: 5.015625
▁gender 1.95703125
, 0.04559326171875
▁age 0.2705078125
, 0.039825439453125
▁country 4.3515625
, 2.30859375
▁type 4.35546875
▁of 0.057647705078125
▁residence 3.66796875
▁( 2.517578125
urban 0.6015625
/ 1.443359375
r 0.1666259765625
ural 0.0008192062377929688
), 0.1678466796875
▁years 6.1015625
▁of 0.1700439453125
▁education 0.763671875
, 0.0885009765625
▁and 1.4443359375
▁employ 2.4140625
ment 0.0020008087158203125
▁status 0.76025390625
. 0.2093505859375
▁Pat 4.5390625
ients 0.09368896484375
▁were 1.1572265625
▁also 0.8720703125
▁asked 0.53955078125
▁about 1.0771484375
▁their 0.7294921875
▁medical 2.828125
▁history 0.505859375
▁over 8.453125
▁the 0.0689697265625
▁years 4.6328125
▁and 1.6513671875
▁the 1.349609375
▁current 3.046875
▁presence 5.046875
▁of 0.07672119140625
▁any 2.49609375
▁severe 3.68359375
▁dise 1.7880859375
ases 8.940696716308594e-05
▁such 4.6015625
▁as 0.00115203857421875
▁heart 2.623046875
▁failure 1.7060546875
, 0.275390625
▁di 1.5859375
ab 0.0008287429809570312
etes 0.002895355224609375
, 0.0670166015625
▁ar 4.11328125
th 0.1668701171875
rit 0.030059814453125
is 0.005397796630859375
, 0.0253448486328125
▁and 1.1630859375
▁so 1.0322265625
▁on 0.06475830078125
. 0.0611572265625
▁The 1.5322265625
▁third 6.95703125
▁measure 3.4140625
▁of 2.49609375
▁the 0.69970703125
▁question 1.712890625
naire 0.2103271484375
▁was 1.17578125
▁indicated 10.5859375
▁by 0.97119140625
▁information 7.4140625
▁on 1.87109375
▁any 5.8359375
▁twelve 14.15625
- 0.2078857421875
month 0.2242431640625
▁and 5.12109375
▁lifetime 0.68798828125
▁drug 3.583984375
▁and 1.6552734375
▁alco 0.1204833984375
hol 6.330013275146484e-05
▁consumption 4.5859375
. 0.449462890625
▁In 3.705078125
▁addition 0.80224609375
, 0.1907958984375
▁the 1.0263671875
▁record 10.359375
▁included 1.4228515625
▁a 2.771484375
▁pain 3.69140625
▁measurement 4.86328125
▁scale 0.452392578125
▁from 2.6875
▁ 0.174560546875
0 0.342041015625
▁to 0.1376953125
▁ 0.00412750244140625
1 0.0139617919921875
0 0.0164642333984375
▁to 3.734375
▁evaluate 1.3046875
▁dis 6.234375
com 0.07470703125
fort 0.0012483596801757812
▁feelings 7.34765625
▁during 4.203125
▁the 0.348876953125
▁last 1.0380859375
▁month 1.5927734375
. 0.2413330078125
